DIRECTORY
BIOTECH
Pharmaclient

   

Quick Click ! Monthly news Home-Site Contactexpress Faqs Legends Companies Events Environment Memories Home-Biotech

Abcys | AB Science | Adocia | Advicenne Pharma | Affichem | Agate Bioservices | Aisa Therapeutics | Alfact Innovation | AliX | Alizé Pharma | Ambiotis | Anaconda Pharma | Aptys Pharmaceuticals | Ariana Pharmaceuticals | Aterovax | Atlantic Bone Screen | Aureus Sciences | B Cell Design | BioAlliance Pharma | Biocortech | BioCydex | BioMedical Diagnostics | Biométhodes | Biom'up | BioProtein Technologies | BioQuanta | BioSystems International | BMSystems (Bio-modeling) | BT Pharma | Carmat | Cellectis | Cellial Technologies | CellProthera | CellVax | Cerenis Therapeutics | Cezanne | CliniGenetics | Covalab | Cytheris | Cytoo | DBV Technologies | DNA Therapeutics | Domain Therapeutics | Dynabio | Edelris | Endotis Pharma | Epixis | ERYtech Pharma | Exonhit | Eye Tech Care | Flamel Technologies | Fluofarma | GemacBio | Genepep | Genewave | Genfit | Genomic Vision | GenoSafe | GenoScience Pharma | Genoscreen | GenOway | Genticel | GTP Technology | Helios Biosciences | Hemarina | Hybrigenics | Hyphen BioMed | Imagene | ImmunId | Immutep | Imstar | In-Cell-Art | Indicia Biotechnology | InGen Biosciences (AbAg) | Innate Pharma | InnaVirVax | Innovative Health Diagnostics | IntegraGen | Ipsogen | I-Stem | Karcinolys | Keosys | Magnisense | Mapreg | MAT Biopharma | Mauna Kea Technologies | Medesis Pharma | Mellitech | Metabolys | MilleGen | Murigenetics | NanoBiotix | Neorphys | Neovacs | Netris-Pharma | Neuronax | NewVectys | NicOx | Nokad | Nosopharm | Novagali | NovoCIB | Novotec | Obe Therapy | Oligovax | Oncodesign | OriBase Pharma (ex-Nova Decision) | Oroxcell | Oxincell | Palumed | PharmaLeads | Pharmaxon | Pharnext | PhenoPro | Pherecydes Pharma | PolyIntell | Proteogenix | Protexel | PX'Therapeutics | Quantum Genomics | Rhenovia Pharma | ScarCell Therapeutics | Sepal Pharma | Serial Genetics | Sisène Biotechnologies | Skuld-Tech | Stentys | Synapcell | Synprosis | Tc Land Expression | Theraclion | Theralpha | TheraVectys | Transgene | Trophos | TxCell | UroGene | UROsphere | Vaxon Biotech | Vectalys | Vivalis | XenTech |

* KARCINOLYS *

 

2005 - Rhône-Alpes
Lyon
www.no-website.net

 

Development, Drugs
Key words: Biologicals, Liver cancer, Pancreatic cancer, Herpes virus
Mission: to develop a new generation of tumour-selective «replication conditional» HSV-1 derived oncolytic viruses
Clients: Pharmaceutical industry
jean-luc.bejot@karcinolys.com

Age: 6 year(s)

 

 

Identity
TYPE/MANAGEMENT/INVESTORSFINANCES/STATUS

Start-up |
Managing Dir.-CEO: Béjot (Jean-Luc) [born 1957, M.D., ex-OPI, Novartis, Quintiles, Genzyme, Ipsen, Cassenne]
Sc.Dir.-CSO:
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned (registered capital 2009 = 0.1 M€)
Communication : no website, yet

Turnover (M€) : 0.001 (2007)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Cancers
Position : Incub
Company confirm : 2-May-2011

 

History
DATEMILESTONETYPETIME
2007 .06 Round-financing : 8 M€ (planned) RFIN [1 year]
2005 .12 Company founded by Jean-Luc Béjot [ex-Opi], Jean-Baptiste de Cabanes, Jacques de Massignac ORGF [0 year]

Actualisation / Updating: 2-May-2011

   

Pharmaclient est le site-conseil de la Valorisation Client en Pharma...
Pour toute Mission, Inscription à la Pharmagalerie, Insertion dans la base Biotech, ou Question: CONTACT



© J.H. Huber, Pharmaclient 2001-2011. Pour retourner à la page d'accueil Biotech: BIENVENUE !       Haut de page : légende